Childhood Cancer Survivor Study
St. Jude Children's Research Hospital · with National Cancer Institute (NCI), Fred Hutchinson Cancer Center · NCT01120353
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 50000
- US sites recruiting
- 27
- Study start
- January 5, 1995
- Record last updated
- June 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximately 50,000 survivors of cancer, diagnosed before 21 years of age, between 1970 and 1999 and 10,000 sibling controls. This project will study children and young adults exposed to specific therapeutic modalities, including radiation, chemotherapy, and/or surgery, who are at increased risk of late-occurring adverse health outcomes. A group of sibling controls will be identified and data collected for comparison purposes.
Conditions: Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Initial Cohort
- Five-year survival following diagnosis of leukemia, lymphoma, CNS tumor, bone tumor, Wilms tumor, neuroblastoma, or soft tissue sarcoma before age 21 years between January 1, 1970 and December 31, 1986 at one of participating centers.
Expanded cohort
- Five-year survival following diagnosis of leukemia, lymphoma, CNS tumor, bone tumor, kidney tumor, neuroblastoma, or rhabdomyosarcoma before age 21 years between January 1, 1987 and December 31, 1999 at one of participating centers.
- English- or Spanish-speaking and living in the U.S. or Canada at the time of diagnosis.
Exclusion Criteria
- Diagnosis of non-malignant tumors (i.e., Langerhans cell histiocytosis, meningioma, craniopharyngioma, etc.) treated with radiation and/or chemotherapy.
- Non-English speaking or residence outside the US or Canada.
Sibling Controls
- For comparison purposes, a group of sibling controls will be identified to represent a stratified random sample based on the distribution of survivors with regard to cancer diagnosis, age, sex, race, and geographic location.
Recruiting US locations
University of Alabama at Birmingham/Children's of Alabama
Birmingham, AL 35294
Site contact: Kimberly Whelan, MD · 202-939-9285 · kwhelan@peds.uab.edu
City of Hope National Medical Center
Duarte, CA 91010
Site contact: Saro Armenian, DO · 626-471-7205 · sarmenian@coh.org
Children's Hospital Los Angeles
Los Angeles, CA 90027
Site contact: David Freyer, DO · 323-361-8953 · DFreyer@chla.usc.edu
University of California-Los Angeles
Los Angeles, CA 90095
Site contact: Jacqueline Casillas, MD · 310-794-2474 · jcasillas@mednet.ucla.edu
Children's Hospital of Orange County
Orange, CA 92868
Site contact: Leonard Sender, MD · 714-509-8636 · lsender@uci.edu
University of California-San Francisco
San Francisco, CA 94143
Site contact: Robert Goldsby, MD · 415-476-3831 · goldsbyr@peds.ucsf.edu
Stanford University School of Medicine
Stanford, CA 94305
Site contact: Sheri Spunt, MD · 650-723-5535 · sspunt@stanford.edu
Children's Hospital Colorado
Aurora, CO 80045
Site contact: Brian Greffe, MD · 720-777-6787 · greffe.brian@tchden.org
Children's National Medical Center
Washington D.C., DC 20010
Site contact: Jennifer Dean, MD · 703-531-3627 · jdean@psvcare.org
Emory University/Children's Health Care of Atlanta
Atlanta, GA 30322
Site contact: Lillian Meacham, MD · 404-727-0480 · lillian.meacham@oz.ped.emory.edu
Ana & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL 60611-2605
Site contact: Jennifer Reichek, MD, MSW · 312-227-4777 · jreichek@luriechildrens.org
University of Chicago
Chicago, IL 60637
Site contact: Tara Henderson, MD, MPH · 773-702-2501
Indiana University/Riley Hospital for Children
Indianapolis, IN 46202
Site contact: Terry Vik, MD · 317-944-8784 · tvik@iupui.edu
Dana-Farber Cancer Institute
Boston, MA 02215
Site contact: Lisa Diller, MD · 617-632-5642 · lisa_diller@dfci.harvard.efu
University of Michigan/Mott Children's Hospital
Ann Arbor, MI 48109
Site contact: Raymond Hutchinson, MD · 734-764-7126 · rhutchin@umich.edu
Children's Hospitals & Clinics of Minnesota
Minneapolis, MN 55404
Site contact: Katharine R. Lange, MD · 612-813-6560 · Katharine.Lange@childrensmn.org
St. Louis Children's Hospital/The Washington University
St Louis, MO 63130
Site contact: Robert Hayashi, PhD · 314-454-4118 · hayashi_r@kids.wustl.edu
Roswell Park Cancer Institute
Buffalo, NY 14263
Site contact: Denise Rokitka, MD · 716-845-2333 · denise.rokitka@roswellpark.org
Memorial-Sloan Kettering Cancer Center
New York, NY 10065
Site contact: Danielle Friedman, MD · 212-639-8138 · friedmad@mskcc.org
Nationwide Children's Hospital
Columbus, OH 43205
Site contact: Randy Olshefski · 614-722-3553 · randal.olshefski@nationwidechildrens.org
Children's Hospital of Philadelphia
Philadelphia, PA 19104
Site contact: Jill Ginsberg, MD · 215-590-7399 · ginsbergji@email.chop.edu
Children's Hospital of Pittsburgh
Pittsburgh, PA 15213
Site contact: Jean Tersak, MD · 412-692-5963 · jean.tersak@chp.edu
St. Jude Children's Research Hospital
Memphis, TN 38105
Site contact: Gregory T. Armstrong, MD, MSCE · 888-226-4343 · ccss@stjude.org
Cook Children's Medical Center
Fort Worth, TX 76104
Site contact: Donald Beam, MD · 682-885-4007 · donald.beam@cookchildrens.org
M.D. Anderson Cancer Center
Houston, TX 77030
Site contact: Louise Strong, MD · 713-792-2589 · lstrong@mdanderson.org
Texas Children's Hospital
Houston, TX 77030
Site contact: ZoAnn E. Dreyer, MD · 832-822-4209 · zdreyer@bcm.edu
Seattle Children's Hospital
Seattle, WA 98105
Site contact: Scott Baker, MD · 206-884-1018 · ksbaker@fhcrc.org
Study contacts (from the official record)
- Gregory T. Armstrong, MD, MSCE · 888-226-4343 · referralinfo@stjude.org
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65